Video

Combining Local and Systemic Therapies in Liver Cancer

Author(s):

Ghassan K. Abou-Alfa, M.D.

Can local and systemic therapies be combined to treat liver cancer?

Ghassan K. Abou-Alfa, M.D., medical oncologist at Memorial Sloan Kettering Cancer Center, discusses the future of combining local and systemic therapy to treat liver cancer.

Currently, there is a divide between local (delivered directly to the tumor) therapy and systemic (given throughout the whole body) therapy in the treatment of liver cancer. However, Abou-Alfa said, "This is about marriage, not divorce," between the two treatment methods, and expects combination regimens to emerge on the scene.

Related Videos
Image of woman with black hair.
Image of a man wearing a black suit and tie.
Image of a man with white hair and a white goatee.
Image of a woman with brown wavy hair, wearing a navy blue top.
Image of a man wearing a suit with a red bowtie.
Image of a man with rectangular glasses and a goatee.
Image of a woman with glasses and dark hair.
Image of a woman wearing a red tank top.
Image of a woman with a brown hair tied into a bun.
Related Content
FDA text.
October 1st 2024

Oncology Drugs Approved by the FDA in September 2024

Darlene Dobkowski, MA
Throughout September, the FDA approved drugs for the treatment of diseases including lung cancer, multiple myeloma, thyroid cancer and breast cancer.
Marshall Morris, the founder of Dying Defiantly
December 8th 2022

Creating a Charity 8 Days After a Rare Cancer Diagnosis: Dying Defiantly Founder Shares His Story

Sailaja Darisipudi Andy Polhamus
After Marshall Morris was diagnosed with a rare cancer and given only six months to live, he created a charity that empowers people with terminal illness and provides them with counseling and support.
illustration of liver.
September 23rd 2024

Steatotic Liver Disease Linked to Improved Survival in Patients With Liver Cancer

Spencer Feldman
Steatotic liver disease was associated with better liver function, lower recurrence rates, and improved overall survival in patients with liver cancer who received radiofrequency ablation.
Making Art From Cancer
December 10th 2020

Making Art From Cancer

Jessica Skarzynski
This week on the “CURE® Talks Cancer” podcast, we spoke with renowned street artist James Cochran about one of his art projects that was commissioned to symbolize the creativity and commitment of those who work tirelessly to eradicate cancer.
Illustration of a liver highlighted in red to signify liver cancer.
September 14th 2024

Lenvima Regimen Offers Benefits in Intermediate Stage Liver Cancer

Ashley Chan
Patients with intermediate-stage liver cancer may benefit from receiving a Lenvima-Keytruda combination with transarterial chemoembolization.
FDA Approves Subcutaneous Tecentriq Formulation
September 12th 2024

FDA Approves Subcutaneous Tecentriq Formulation

Darlene Dobkowski, MA
Tecentriq Hybreza, a subcutaneous delivery of the drug, was approved for certain types of sarcoma, in addition to lung, skin and liver cancers.